期刊文献+

瑞芬太尼与丙泊酚全凭静脉麻醉对开胸手术患者苏醒时间的影响 被引量:2

Effect of awakening time during total intravenous remifentanil-propofol anesthesia to patients with thoracic surgery
下载PDF
导出
摘要 目的探讨瑞芬太尼与丙泊酚全凭静脉麻醉对开胸手术患者苏醒时间的影响。方法50例ASAⅠ~Ⅱ级择期行开胸手术患者,随机分为2组,A组(瑞芬太尼与丙泊酚组)25例,术中瑞芬太尼与丙泊酚持续泵入维持麻醉;B组(芬太尼与咪达唑仑组n=25例),术中芬太尼与咪达唑仑持续泵入维持麻醉。术中根据血压及心律的变化调整输注速度,维持血压及心率在基础值±20%范围内。观察患者苏醒时间、拔管时间及警觉/镇静评分(OAA/S)。结果苏醒时间、拔答时间A组与B组比较有著性差异(P<0.05),A组的苏醒时间、拔管时间最短,且术后苏醒质量评分最佳。结论瑞芬太尼与丙泊酚持续输注维持全凭静脉麻醉由于开胸手术,苏醒最快、质量最佳。 Objective To study the effect of awakening time during total intravenous remifentanil - propofol anesthesia to patients with thoracic surgery. Methods Fifty patients ASA ( I -Ⅱ) scheduled for thoracic surgery were randomly divided into two groups : for gxoup A, ( remifentanil and propofol, n = 25 ), Operation during the maintenance of anesthesia with remifentanil and propofol continuous infusion and group B( fentanyl and midazolam, n = 25 ), during the maintenance of anesthesia with fentanyl and midazolam continuous infusion. Operation duTing according to changes in blood pressure and cardiac rhythm adjustment infusion rate, blood pressure and heart rate within ±20% range of basic value. The time of awakening, extubation, and the alertness/sedation score(OAA/S) were recorded. Results In two groups, awakening time and extubation time were of significant difference. The awakening and extubation time in group A was shorter than groups B. The awakening quality in group A was the better than group B. Conclusions Remifentanil and propofol continuous infusion of total intravenous anesthesia in the patients with thoracic surgery may have the awakening time and the best quality on analepsia.
作者 岳修勤
出处 《医学信息(手术学分册)》 2008年第9期799-801,共3页 Medical Information Operations Sciences Fascicule
关键词 瑞芬太尼 丙泊酚 全凭静脉麻醉 苏醒时间 remifentanil propofol total intravenous anesthesia awakening time
  • 相关文献

参考文献2

二级参考文献29

  • 1Salihoglu Z, Demiroluk S, Demirkiran O, et al. Comparison of effects of remifentanil ,alfentanil and fentanyl on cardiovascular responses to tracheal intubation in morbidly obese patients. Eur J Anaesthesiol, 2002, 19(2):125 - 128.
  • 2Hwan S , William J, Sasam E. Sevoflurane with remifentanil allow rapid tracheal intubation without neuromuscular blocking agents. Can J Anaesth,2001,48(7) :646 -650.
  • 3Lee PL, Kua SW, Chiu KY. The use of remifentanil to facilitate the insertion of the laryngeal mask airway. Anesth Analg, 2001,93:359-362.
  • 4Dershwitz M, Kandel GI,Rosow CE, et al . Initial clinical experience with remifentanil, a new opiod metabolized by esterases. Anesth Analg, 1995,81:619 -623.
  • 5Paventi S, Santevecchi A, Perilli V, et al. Effects of remifentanil infusion bis -titrated on early recovery for obese outpatient undergoing laparoscopic cholecystectomy . Minerva-Anesthesiol. 2002 ;68(9):651-657.
  • 6OHare RA, Mirakhur RK, Reid JE, et al. Recovery from propofol anaesthesia supplement with remifentanil . Br J Anaesth, 2001, 86(3) :361 -365.
  • 7Van - Delden PG, Houweling PL, Bencini AF, et al. Remifentanilsevoflurane anaesthesia for laparoscopic cholecystectomy: comparison of three close regimens . Anaesthesia, 2002, 57(3) :212 -217.
  • 8Mcztens M J, Engbers FH, Burm AG, et al. Predictive performance of computer -controlled infusion of remifentanil during propofol/remifentanil anaesthesia.. Br J Anaesth, 2003, 90:132-141.
  • 9Bouillon J, Brahn J, Radu - Radulescu L ,et al. Non -steady state analysis of the pharmacokinetic interaction between propofol and remifentanil.Anesthesiology, 2002, 97:1350 - 1362.
  • 10Elliott P, OHare R, Bill KM, et al. Severe cardiovascular depression with remifentanil.Anesth Analg,2002,91(1):58-61.

共引文献595

同被引文献25

  • 1郭坤亮,季克良,王昌禄.酒精代谢及其相关基因遗传多态性[J].酿酒科技,2005(7):36-38. 被引量:9
  • 2孙庆文.酒精饮料在人体内的代谢及适宜饮量[J].酿酒科技,2006(8):126-127. 被引量:16
  • 3王长连,许雄伟,林财珠,许建华,黄品芳,刘亦伟.不同年龄组全麻手术病人丙泊酚药动学研究[J].中国药学杂志,2007,42(3):209-212. 被引量:7
  • 4宋文学,穆皋生,李万福,等.丙泊酚混合瑞芬太尼静脉麻醉853例临床分析[J].中国医师进修杂志,2009,32(增刊):132.
  • 5彭娅.贾振飞,程刚.丙泊酚及其制剂的研究进展[J].中国药剂学杂志,2012,10(1):17-25.
  • 6AI-Jahadai WS, Yamamoto K, Hiraoka H,et al.Prediction oftotal propofol clearance based on enzyme activities in micro-SOllles from human kidney and liver.Eur J Clin Pharmacol,2009; 62(23):527-533.
  • 7Cichoz-I aeh H, Pm'tycka J, Nesina k et al .Genetic polymer-phi,sa- of alcohol dehy&ogenase 3 in digestive tract aleoholdamage.Hepatogastroenlerology, 2007; 54:1222-1227.
  • 8H iraoka H.Yamamoto K, M iyoshi S, et al .Kidneys contribute to the extrahepatic clearance of propofol in humans,but not lungs and brain.Br J Clin Pharmacol, 2008; 60(21 ): 176.-182.
  • 9Fassoulaki A,Farinotti R,Servin F,et al.Chronic alco- holism increases the induction dose of propofol in humans [J].Anesth Analg, 1993,77 : 553-556.
  • 10Servin FS,Bongeois B,Gomeni R,et al. Pharmacokinetics of propofol administered by target-controlled infusion to alcoholic patients[J]. Anesthesiology, 2003,99(3) : 576-585.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部